English
Dom
O CPF-u
O nama
CPF R&D
Factory Style
Video
Proizvodi
FAQs
Vijesti
Company News
Industry News
Kontaktirajte nas
Dom
Proizvodi
Otesekonazol
Kratak opis:
Ime API-ja
Indikacija
Inovator
Datum isteka patenta (SAD)
Otesekonazol
Smanjite stopu incidencije
rekurentna vulvovaginalna kandidijaza
MycoviaPharmaceuticals
Apr.22,2031
Pošaljite nam email
Detalji o proizvodu
Oznake proizvoda
Prethodno:
Finerenon
sljedeće:
Semaglutid
Napišite svoju poruku ovdje i pošaljite nam je
Kategorije proizvoda
Paxlovid
Crisaborole
Daklatasvir dihidroklorid
Relugolix 737789-87-6
Hidroklorotiazid
Elagolix 834153-87-6
Pritisnite enter za pretragu ili ESC da zatvorite
English
French
German
Portuguese
Spanish
Russian
Japanese
Korean
Arabic
Irish
Greek
Turkish
Italian
Danish
Romanian
Indonesian
Czech
Afrikaans
Swedish
Polish
Basque
Catalan
Esperanto
Hindi
Lao
Albanian
Amharic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Bulgarian
Cebuano
Chichewa
Corsican
Croatian
Dutch
Estonian
Filipino
Finnish
Frisian
Galician
Georgian
Gujarati
Haitian
Hausa
Hawaiian
Hebrew
Hmong
Hungarian
Icelandic
Igbo
Javanese
Kannada
Kazakh
Khmer
Kurdish
Kyrgyz
Latin
Latvian
Lithuanian
Luxembou..
Macedonian
Malagasy
Malay
Malayalam
Maltese
Maori
Marathi
Mongolian
Burmese
Nepali
Norwegian
Pashto
Persian
Punjabi
Serbian
Sesotho
Sinhala
Slovak
Slovenian
Somali
Samoan
Scots Gaelic
Shona
Sindhi
Sundanese
Swahili
Tajik
Tamil
Telugu
Thai
Ukrainian
Urdu
Uzbek
Vietnamese
Welsh
Xhosa
Yiddish
Yoruba
Zulu
Kinyarwanda
Tatar
Oriya
Turkmen
Uyghur